NuggMD, the leading platform U.S. patients turn to for access to medical cannabis evaluations, has begun serving patients in Germany at https://nuggmd.de. This expansion represents the California-based company's first entry into an international market and marks the inaugural instance of a U.S.-based cannabis telehealth platform expanding across national borders.
The company brings a decade of operational experience from the United States, where cannabis remains criminalized at the federal level despite varying degrees of state-level legalization. This regulatory contradiction has historically impeded patient access to medical cannabis treatments. Germany's centralized approach to medical cannabis regulation presents a contrasting model that has demonstrated effectiveness in ensuring patient access.
According to a recent survey of more than 11,000 German cannabis consumers, nearly 90% obtain their cannabis from legal sources, with a near-universal preference for consumption on personal property rather than in public spaces. This data suggests Germany's patient-centric regulatory framework is functioning effectively for all stakeholders involved. The German system allows patients to purchase cannabis immediately following an affirmative medical determination, creating a more streamlined patient experience compared to fragmented approaches.
Charlie Russell, CEO of NuggMD, stated that operating successfully in the complex U.S. market has provided the perspective and institutional knowledge necessary to function effectively in any medical cannabis market. The company's expansion reflects its mission to help people access plant-based medicine where legal, emphasizing that individuals should have the freedom to make informed wellness decisions under medical guidance.
The move into Germany signals potential for broader European Union expansion, as cannabis markets in the EU region appear poised for rapid growth due to appropriate policy approaches. NuggMD's established track record includes connecting more than 2 million patients with medical marijuana doctors since its 2015 founding through its state-of-the-art telehealth platform at https://www.nuggmd.com. This international expansion could establish new standards for medical cannabis access in regulated markets worldwide while demonstrating the scalability of telehealth solutions for plant-based medicine.
